INGN Q3 2023 Earnings — Inogen, Inc. Revenue & Financial Results | Market Cap Arena

INGNInogen, Inc.

$171M

Q3 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$84M-20.3% YoY

Gross Profit

$34M40.2% margin

Operating Income

-$47M-55.6% margin

Net Income

-$46M-54.4% margin

EPS (Diluted)

$-1.97

QoQ Revenue Growth

+0.4%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

-$3M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$344M

Total Liabilities

$113M

Stockholders' Equity

$231M

Cash & Equivalents

$125M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$84M	$105M	-20.3%
Gross Profit	$34M	$43M	-21.1%
Operating Income	-$47M	-$10M	-354.0%
Net Income	-$46M	-$10M	-380.9%

Geographic Segments

UNITED STATES

$58M69%

Non-US

$26M31%